436 related articles for article (PubMed ID: 22532131)
1. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
Groblewska M; Siewko M; Mroczko B; Szmitkowski M
Folia Histochem Cytobiol; 2012 Apr; 50(1):12-9. PubMed ID: 22532131
[TBL] [Abstract][Full Text] [Related]
2. [The role of selected matrix metalloproteinases and their inhibitors in colorectal cancer development].
Groblewska M; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw (Online); 2010 Jan; 64():22-30. PubMed ID: 20173217
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study.
Hirano H; Tsuji M; Kizaki T; Sashikata T; Yoshi Y; Okada Y; Mori H
Med Electron Microsc; 2002 Mar; 35(1):16-23. PubMed ID: 12111403
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.
Adithi M; Nalini V; Kandalam M; Krishnakumar S
J Pediatr Hematol Oncol; 2007 Jun; 29(6):399-405. PubMed ID: 17551402
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
6. [The role of metalloproteinases and their inhibitors in pancreatic cancer].
Łukaszewicz M; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw (Online); 2008 Apr; 62():141-7. PubMed ID: 18414340
[TBL] [Abstract][Full Text] [Related]
7. Enhanced cell surface expression of matrix metalloproteinases and their inhibitors, and tumor-induced host response in progression of human gastric carcinoma.
Koyama S
Dig Dis Sci; 2004 Oct; 49(10):1621-30. PubMed ID: 15573916
[TBL] [Abstract][Full Text] [Related]
8. Gastric cancer - The role of matrix metalloproteinases in tumor progression.
Lukaszewicz-Zając M; Mroczko B; Szmitkowski M
Clin Chim Acta; 2011 Sep; 412(19-20):1725-30. PubMed ID: 21693112
[TBL] [Abstract][Full Text] [Related]
9. [Matrix metalloproteinases and their tissue inhibitors in malignancies of the female genital tract].
Piura B; Rabinovich A; Huleihel M
Harefuah; 2003 Nov; 142(11):786-91, 804. PubMed ID: 14631913
[TBL] [Abstract][Full Text] [Related]
10. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.
Goffin F; Munaut C; Frankenne F; Perrier D'Hauterive S; Béliard A; Fridman V; Nervo P; Colige A; Foidart JM
Biol Reprod; 2003 Sep; 69(3):976-84. PubMed ID: 12773401
[TBL] [Abstract][Full Text] [Related]
11. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions.
Galateau-Salle FB; Luna RE; Horiba K; Sheppard MN; Hayashi T; Fleming MV; Colby TV; Bennett W; Harris CC; Stetler-Stevenson WG; Liotta L; Ferrans VJ; Travis WD
Hum Pathol; 2000 Mar; 31(3):296-305. PubMed ID: 10746671
[TBL] [Abstract][Full Text] [Related]
14. Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human glioblastoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2014 Aug; 45(2):887-94. PubMed ID: 24867464
[TBL] [Abstract][Full Text] [Related]
15. The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.
Herszényi L; Hritz I; Lakatos G; Varga MZ; Tulassay Z
Int J Mol Sci; 2012 Oct; 13(10):13240-63. PubMed ID: 23202950
[TBL] [Abstract][Full Text] [Related]
16. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
17. [The significance of metalloproteinases and their inhibitors in gastric cancer].
Lukaszewicz-Zajac M; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw (Online); 2009 Jun; 63():258-65. PubMed ID: 19502687
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases and the thyroid.
Kraiem Z; Korem S
Thyroid; 2000 Dec; 10(12):1061-9. PubMed ID: 11201850
[TBL] [Abstract][Full Text] [Related]
19. [The expression of matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs) and angiogenesis in relation to the depth of tumor invasion and lymph node metastasis in submucosally invasive colorectal carcinoma].
Jung SA; Yang SK; Kim JS; Shim KN; Im SA; Myung SJ; Jung HY; Yu CS; Kim JC; Hong WS; Kim JH; Min YI
Korean J Gastroenterol; 2005 Jun; 45(6):401-8. PubMed ID: 15973074
[TBL] [Abstract][Full Text] [Related]
20. Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis.
Khasigov PZ; Podobed OV; Gracheva TS; Salbiev KD; Grachev SV; Berezov TT
Biochemistry (Mosc); 2003 Jul; 68(7):711-7. PubMed ID: 12946252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
